Skip to Main Content

Paper Details

Use of dasatinib dose-reduction periods to remedy poor surgical wound healing in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Leuk Lymphoma
1
2020
Author NameAffiliation
Michael W DeiningerUniversity of Utah, Huntsman Cancer Institute
  • 1 - 1

Datasets

Release 1.2